STOK
STOK
US86150R1077
Stoke Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 184.420.000 36.555.000
404.5%
Cost of Revenue -- --
--
Gross Profit -- --
--
205.010.000 137.927.000
48.6%
Operating Income -20.590.000 -101.372.000
79.7%
Pretax Income -6.885.000 -88.981.000
92.3%
Net Income Common Stockholders -6.885.000 -88.981.000
92.3%
-- --
--
-- --
--
ende